ArticleCureus2026

Bridging the Gap Between Regulatory Approval and Patient Access: The Case for Insurance Coverage of Approved Allogeneic Stem Cell Therapy in Knee Osteoarthritis.

Amit Kumar Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.